Bausch + Lomb Announces Statistically Significant Topline Results from Second Phase 3 Trial of NOV03
Wednesday, October 6 2021 | 11 h 29 min | News, Press Release
Bausch + Lomb and Novaliq announced statistically significant topline data from the second Phase 3 (MOJAVE) trial evaluating the investigational...
Read More